Forest Investigative Site 022 — Dayton, Ohio

Forest Investigative Site 022 is a clinical research site located in Dayton, Ohio, United States 45417.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Forest Investigative Site 022 has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: Forest Laboratories.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 022?

Forest Investigative Site 022 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 022 conducted?

Forest Investigative Site 022 has 1 clinical trials on record. Their work covers Schizophrenia.

Is Forest Investigative Site 022 accredited by Crixeo Health?

Forest Investigative Site 022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 022?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.